Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
Celgene
M.D. Anderson Cancer Center
Medical College of Wisconsin
Case Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Weill Medical College of Cornell University
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
City of Hope Medical Center
Thomas Jefferson University
Thomas Jefferson University
City of Hope Medical Center